Advanced Myelodysplastic Syndromes

2 clinical trials · Condition

Record	Firm	Date
Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS (NCT03459859)	Justin Watts, MD	2018-05-21
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) (NCT00629798)	Memorial Sloan Kettering Cancer Center	2008-02-12

Every clearance here is in the API, with alerts when new ones post.